|
Delayed
Nasdaq
20:13:13 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.050 USD | -3.67% |
|
+0.26% | -50.70% |
| 08-21 | ABVC BioPharma, Inc. completed the Spin-Off of BioKey, Inc. | CI |
| 08-12 | ABVC BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.67% | +0.26% | +0.96% | +3.96% | -50.70% | -62.09% | -13.22% | -95.87% | -99.71% | 28.3M | |
| +0.34% | -3.03% | -11.69% | +16.15% | +57.65% | +37.45% | +61.06% | +6.44% | - | 64.14B | |
| +0.98% | +2.68% | -5.19% | +3.71% | +12.22% | +12.25% | +83.90% | +210.70% | +5,645.71% | 55.53B | |
| +1.75% | +2.01% | +9.73% | +11.48% | +19.15% | +13.30% | +105.71% | -14.63% | +243.04% | 53.03B | |
| -1.69% | -0.97% | +2.47% | +11.34% | +22.28% | +26.53% | +55.58% | +5.44% | +284.21% | 45.99B | |
| -0.79% | -3.09% | +1.42% | +13.21% | +21.93% | +17.66% | +98.51% | +3.56% | +1,014.44% | 42.45B | |
| +0.18% | +0.95% | -7.34% | +4.73% | +137.88% | +226.56% | +932.53% | +543.80% | - | 40.45B | |
| -0.26% | -4.20% | +6.17% | +6.71% | +9.81% | +10.86% | +45.18% | +6.84% | +157.79% | 32.25B | |
| -2.07% | +42.73% | +63.49% | +102.89% | +86.88% | +103.77% | +90.26% | +31.35% | +238.82% | 34.47B | |
| -2.72% | -8.79% | -15.62% | +16.80% | +43.32% | +22.58% | -5.63% | -60.89% | - | 24.23B | |
| +0.36% | -1.47% | -10.36% | -4.94% | -7.19% | -14.51% | -5.25% | -68.30% | - | 22.1B | |
| +14.29% | +15.39% | -5.14% | +6.37% | -36.97% | -34.30% | +360.88% | +263.81% | +745.07% | 21.18B | |
| -1.42% | +4.58% | +9.94% | +16.92% | +21.77% | +17.00% | +182.85% | +201.88% | +2,256.72% | 19.38B | |
| +0.76% | +11.51% | +27.97% | +61.30% | +89.86% | +110.24% | +130.21% | -15.59% | +399.13% | 17.85B | |
| +0.97% | +4.59% | +14.28% | +26.86% | +39.55% | +43.70% | +86.35% | -14.58% | +110.39% | 16.69B | |
| -0.84% | +0.91% | +12.37% | +19.11% | +50.37% | +67.14% | +225.62% | +206.39% | +522.33% | 16.42B | |
| +0.71% | +3.08% | +9.82% | -0.63% | - | - | - | - | - | 16.39B | |
| +3.33% | +5.53% | +7.36% | +11.21% | +192.66% | +175.10% | +360.46% | +1,478.53% | +825.12% | 15.33B | |
| +0.85% | +16.46% | +26.77% | +21.20% | +18.52% | +30.14% | -9.31% | -24.69% | +169.01% | 16.04B | |
| +0.97% | -7.48% | -3.82% | -13.90% | +11.63% | +3.79% | +468.94% | - | - | 13.21B | |
| Average | +0.61% | +4.12% | +6.68% | +16.72% | +38.98% | +42.48% | +171.30% | +148.01% | +893.72% | 28.36B | |
| Weighted average by Cap. | +0.54% | +3.36% | +4.96% | +17.32% | +42.23% | +46.65% | +169.18% | +124.04% | +1,262.77% |
- Stock Market
- Stocks
- ABVC Stock
- Sector ABVC BioPharma, Inc.
Select your edition
All financial news and data tailored to specific country editions
